National Healthcare Properties (NASDAQ:NHP) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of National Healthcare Properties (NASDAQ:NHPFree Report) to a hold rating in a research note issued to investors on Tuesday morning,Zacks.com reports.

A number of other brokerages have also recently issued reports on NHP. Royal Bank Of Canada started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set a “sector perform” rating and a $15.00 target price for the company. Wells Fargo & Company started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set an “overweight” rating and a $16.00 target price for the company. The Goldman Sachs Group started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 target price for the company. Robert W. Baird started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set an “outperform” rating and a $17.00 target price for the company. Finally, KeyCorp started coverage on National Healthcare Properties in a research report on Monday, May 18th. They set a “sector weight” rating for the company. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $17.13.

View Our Latest Stock Analysis on NHP

National Healthcare Properties Price Performance

Shares of National Healthcare Properties stock opened at $13.98 on Tuesday. National Healthcare Properties has a 12-month low of $11.25 and a 12-month high of $15.40.

Featured Stories

Analyst Recommendations for National Healthcare Properties (NASDAQ:NHP)

Receive News & Ratings for National Healthcare Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Healthcare Properties and related companies with MarketBeat.com's FREE daily email newsletter.